Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo Pureco Pratama Tbk. (IPPE) vs Merck Tbk. (MERK) Price & Performance

Indo Pureco Pratama Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo Pureco Pratama Tbk. vs Merck Tbk. — how do they compare? Indo Pureco Pratama Tbk. trades at Rp14 (market cap 64.4B), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 27.3× Indo Pureco Pratama Tbk.'s market cap. Which is the better fit depends on your goals.

IPPEMERK
Market Cap
64.4B1.76T
Volume
63K
Lot
630
Turnover
243.97M
Average Price
3,872.46
Value
243.97M
Indicative Equilibrium Price
3,900
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MERK
View details

About Indo Pureco Pratama Tbk.

PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.

Read more on IPPE

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK